G1 Therapeutics Statistics
Total Valuation
GTHX has a market cap or net worth of $204.42 million. The enterprise value is $186.07 million.
| Market Cap | 204.42M |
| Enterprise Value | 186.07M |
Important Dates
The next confirmed earnings date is Thursday, August 8, 2024, before market open.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
GTHX has 52.28 million shares outstanding. The number of shares has increased by 1.01% in one year.
| Shares Outstanding | 52.28M |
| Shares Change (YoY) | +1.01% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 11.04% |
| Owned by Institutions (%) | 33.86% |
| Float | 43.82M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.43 |
| Forward PS | 2.72 |
| PB Ratio | 7.37 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.21 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 1.70.
| Current Ratio | 2.94 |
| Quick Ratio | 2.36 |
| Debt / Equity | 1.70 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.08 |
Financial Efficiency
Return on equity (ROE) is -74.80% and return on invested capital (ROIC) is -30.51%.
| Return on Equity (ROE) | -74.80% |
| Return on Assets (ROA) | -24.30% |
| Return on Capital (ROIC) | -30.51% |
| Revenue Per Employee | $840,410 |
| Profits Per Employee | -$305,910 |
| Employee Count | 100 |
| Asset Turnover | 0.67 |
| Inventory Turnover | 0.49 |
Taxes
In the past 12 months, GTHX has paid $3.12 million in taxes.
| Income Tax | 3.12M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +64.29% in the last 52 weeks. The beta is 1.54, so GTHX's price volatility has been higher than the market average.
| Beta (5Y) | 1.54 |
| 52-Week Price Change | +64.29% |
| 50-Day Moving Average | 3.23 |
| 200-Day Moving Average | 3.13 |
| Relative Strength Index (RSI) | 71.67 |
| Average Volume (20 Days) | 1,185,311 |
Short Selling Information
The latest short interest is 7.03 million, so 13.46% of the outstanding shares have been sold short.
| Short Interest | 7.03M |
| Short Previous Month | 5.69M |
| Short % of Shares Out | 13.46% |
| Short % of Float | 16.05% |
| Short Ratio (days to cover) | 4.45 |
Income Statement
In the last 12 months, GTHX had revenue of $84.04 million and -$30.59 million in losses. Loss per share was -$0.62.
| Revenue | 84.04M |
| Gross Profit | 77.23M |
| Operating Income | -22.83M |
| Pretax Income | -27.48M |
| Net Income | -30.59M |
| EBITDA | -18.05M |
| EBIT | -18.55M |
| Loss Per Share | -$0.62 |
Balance Sheet
The company has $65.44 million in cash and $47.09 million in debt, giving a net cash position of $18.35 million or $0.35 per share.
| Cash & Cash Equivalents | 65.44M |
| Total Debt | 47.09M |
| Net Cash | 18.35M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 27.74M |
| Book Value Per Share | 0.53 |
| Working Capital | 63.24M |
Cash Flow
In the last 12 months, operating cash flow was -$18.18 million and capital expenditures $1,000, giving a free cash flow of -$18.18 million.
| Operating Cash Flow | -18.18M |
| Capital Expenditures | 1,000 |
| Free Cash Flow | -18.18M |
| FCF Per Share | -$0.35 |
Margins
Gross margin is 91.89%, with operating and profit margins of -27.16% and -36.40%.
| Gross Margin | 91.89% |
| Operating Margin | -27.16% |
| Pretax Margin | -32.69% |
| Profit Margin | -36.40% |
| EBITDA Margin | -21.48% |
| EBIT Margin | -22.07% |
| FCF Margin | -21.63% |
Dividends & Yields
GTHX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.01% |
| Shareholder Yield | -1.01% |
| Earnings Yield | -14.96% |
| FCF Yield | -8.89% |
Analyst Forecast
The average price target for GTHX is $8.00, which is 104.60% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 104.60% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | 15.49% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GTHX has an Altman Z-Score of -8.22 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -8.22 |
| Piotroski F-Score | 3 |